In patients with attention deficit hyperactivity disorder (ADHD), stimulant medications (i.e amphetamine and methylphenidate) that block DAT and enhance DA signaling are widely used therapeutically to improve attention [2], [14]. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.